New [tmco]
Anti-Obesity Agents [phsu]
lorcaserin [orch, phsu]
Belviq [orch, phsu]
PHENTERMINE/TOPIRAMATE [phsu]
Qsymia [orch, phsu]
Obesity [dsyn]
Risk factor [qnco]
Wide [spco]
Range [qnco]
condition [dsyn]
Including [ftcn]
Cardiovascular disease [dsyn]
Life Style [socb]
Modification [ftcn]
Management [ocac]
Obesity [dsyn]
Pharmacologic Agent [phsu]
Help [socb]
Addition [ftcn]
Patients [podg]
Comorbidities [idcn]
Not [ftcn]
Diet [food]
Exercise [dora]
lorcaserin [orch, phsu]
PHENTERMINE/TOPIRAMATE [phsu]
Long [qlco]
Agent [chvf]
Approved [qlco]
Obesity [dsyn]
Management [ocac]
orlistat [orch, phsu]
Received [qlco]
Food and Drug Administration [hcro]
Approval [qlco]
lorcaserin [orch, phsu]
Serotonin Agonist [phsu]
PHENTERMINE/TOPIRAMATE [phsu]
Combination [qlco]
Sympathomimetic agent [phsu]
antiepileptic drug [phsu]
Agent [chvf]
Show [inpr]
To [qlco]
weight [orga]
CARDIOVASCULAR [bdsy]
Metabolic [ftcn]
Parameters [fndg]
Blood Pressure [orgf]
Lipids [lipd]
HbA [aapp, bacs]
This [euka]
Article [inpr]
Review [inpr]
Pharmacology [bmod]
Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
Agent [chvf]
Three [qnco]
Available [ftcn]
Agent [chvf]
Long-term [tmco]
Management [ocac]
Obesity [dsyn]
Examined [fndg]
